StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Tempest Therapeutics, Inc.
NasdaqCM:TPST
Sector
Industries
Location
Market Cap
USD 25.59 M
Share Price
USD 6.95
Avg Daily Volume
120,730
Change (1 day)
-5.57%
Change (1 year)
Change (YTD)
-34.86%
Tempest Therapeutics, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2025: USD 369.00 K
Tempest Therapeutics, Inc. Depreciation And Amortization is USD 369.00 K for the Trailing 12 Months (TTM) ending March 31, 2025. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
-
Tempest Therapeutics, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 655.00 K, a 62.13% change year over year.
-
Tempest Therapeutics, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 404.00 K, a 25.08% change year over year.
-
Tempest Therapeutics, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 323.00 K, a -73.22% change year over year.
Competitors
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Thermo Fisher Scientific Inc.
USD 434.86
TMO
+4.13
0.96%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Boston Scientific Corporation
USD 103.20
BSX
-0.66
-0.64%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
CSL Limited
USD 158.31
CSL.AX
-1.36
-0.85%
Siemens Healthineers AG
USD 53.86
SHL.DE
-2.12
-3.79%
Regeneron Pharmaceuticals, Inc.
USD 567.74
REGN
+7.98
1.43%
Key Data
| Date | Depreciation And Amortization | Dividends Paid | Common Stock Issued | Common Stock Repurchased |
|---|
Competitors
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Thermo Fisher Scientific Inc.
USD 434.86
TMO
+4.13
0.96%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Boston Scientific Corporation
USD 103.20
BSX
-0.66
-0.64%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
CSL Limited
USD 158.31
CSL.AX
-1.36
-0.85%
Siemens Healthineers AG
USD 53.86
SHL.DE
-2.12
-3.79%
Regeneron Pharmaceuticals, Inc.
USD 567.74
REGN
+7.98
1.43%